Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Il-Yeon Park"'
Autor:
Jung-Seok Lee, Mabel Carabali, Jacqueline K. Lim, Victor M. Herrera, Il-Yeon Park, Luis Villar, Andrew Farlow
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Dengue has been prevalent in Colombia with high risk of outbreaks in various locations. While the prediction of dengue epidemics will bring significant benefits to the society, accurate forecasts have been a challenge. Given compe
Externí odkaz:
https://doaj.org/article/832cc3f17c6641c29610cd2437ae87bb
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 9, Pp 2017-2024 (2017)
A Typhoid Conjugate Vaccine (TCV) is expected to acquire WHO prequalification soon, which will pave the way for its use in many low- and middle-income countries where typhoid fever is endemic. Thus it is critical to forecast future vaccine demand to
Externí odkaz:
https://doaj.org/article/29eed9247a7045a8a2bce3ddfa2ae1fa
Autor:
Ganesh, Kumar Rai, Tarun, Saluja, Shipra, Chaudhary, Dipesh, Tamrakar, Piush, Kanodia, Bishnu Rath, Giri, Rajeev, Shrestha, Surendra, Uranw, Deok Ryun, Kim, Jae Seung, Yang, Il-Yeon, Park, Seung-Eun, Kyung, Sridhar, Vemula, Jagadeesh, Reddy E, Bomi, Kim, Birendra Prasad, Gupta, Sue Kyoung, Jo, Ji Hwa, Ryu, Ho Keun, Park, Jong Hoon, Shin, Yoonyeong, Lee, Hun, Kim, Jerome H, Kim, Zenaida Reynoso, Mojares, T Anh, Wartel, Sushant, Sahastrabuddhe
Publikováno v:
The Lancet Infectious Diseases. 22:529-540
Typhoid fever is an endemic disease in many low-income and middle-income countries. The 2018 WHO position paper recommends that countries should consider typhoid vaccination in high-risk groups and for outbreak control. To address the typhoid vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58acd48f8ca853113fb309757ea01443
https://doi.org/10.1016/s1473-3099(21)00455-2
https://doi.org/10.1016/s1473-3099(21)00455-2
Autor:
Tarun Saluja, Ganesh Kumar Rai, Shipra Chaudhary, Piush Kanodia, Bishnu Rath Giri, Deok Ryun Kim, Jae Seung Yang, Il-Yeon Park, Seung-Eun Kyung, Sridhar Vemula, Jagadeesh Reddy E, Bomi Kim, Birendra Prasad Gupta, Sue Kyoung Jo, Ji Hwa Ryu, Ho Keun Park, Jong Hoon Shin, Yoonyeong Lee, Hun Kim, Jerome H. Kim, Zenaida Reynoso Mojares, T. Anh Wartel, Sushant Sahastrabuddhe
Publikováno v:
Vaccine. 40(40)
Typhoid fever is a common disease in developing countries especially in the Indian subcontinent and Africa. The available typhoid conjugate vaccines (TCV) have been found to be highly immunogenic in infants and children less than 2 years of age. Many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33156db90f589dcd09d8556703a8be13
https://pubmed.ncbi.nlm.nih.gov/36064672
https://pubmed.ncbi.nlm.nih.gov/36064672
Publikováno v:
Human Vaccines & Immunotherapeutics
A Typhoid Conjugate Vaccine (TCV) is expected to acquire WHO prequalification soon, which will pave the way for its use in many low- and middle-income countries where typhoid fever is endemic. Thus it is critical to forecast future vaccine demand to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf4071c7e5aa5e2cb1913549da51c799
http://europepmc.org/articles/PMC5612352
http://europepmc.org/articles/PMC5612352